Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Artif Organs. 2019 May 29;43(9):913–920. doi: 10.1111/aor.13473

Table 2.

Questions discussed in our individual patient education session

General information about Hepatitis C Virus What is Hepatitis C infection?
How can a person get Hepatitis C infection?
What are the different types of Hepatitis C?
Can you get Hepatitis C from being in this study?
Are there any treatments for Hepatitis C infection?
Physical effects of Hepatitis C What happens when you get Hepatitis C?
Are there any other effects of Hepatitis C on other parts of the body?
Hepatitis C and kidney donation Can people with Hepatitis C donate a kidney?
How do you know that a kidney donor has Hepatitis C infection?
Why are there many donors with Hepatitis C infection?
Specific details about the study Does grazoprevir plus elbasvir treat all types of Hepatitis C?
When would the grazoprevir plus elbasvir treatment begin?
How long will I take grazoprevir plus elbasvir?
How long will I be a part of this study?
When will my study visits take place?
Will participating in this study effect my transplant medications or my transplant care?
Does being a part of this study affect my standing on the kidney transplant list? If I decide not to participate does this affect my standing on the kidney transplant list?
What are the side effects of grazoprevir plus elbasvir?
Has anyone like me who does not have Hepatitis C ever received a kidney transplant from a patient with Hepatitis C before?
What are the benefits to being in this study?

For full text of education session see Supplemental Materials.